20
Participants
Start Date
December 17, 2018
Primary Completion Date
March 31, 2022
Study Completion Date
March 31, 2022
LYS-SAF302
Treatment will involve direct injections of the investigational product into both sides of the brain through image-guided tracks, in a single neurosurgical session.
Amsterdam UMC, Amsterdam
University Medical Center Hamburg-Eppendorf, Hamburg
University of Minnesota, Minneapolis
Armand Trousseau Public Hospital, Paris
Baylor college of medicine / Texas children's hospital, Houston
CHOC Children's, Orange
Weill Cornell Medical College, New York
Great Ormond Street Hospital, London
Lead Sponsor
LYSOGENE
INDUSTRY